- 関
- metformin-glyburide
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- Metformin in combination with various insulin secretagogues in type 2 diabetes and associated risk of cardiovascular morbidity and mortality--a retrospective nationwide study.
- Mogensen UM1, Andersson C2, Fosbøl EL3, Schramm TK4, Vaag A5, Scheller NM6, Torp-Pedersen C6, Gislason G7, Køber L3.
- Diabetes research and clinical practice.Diabetes Res Clin Pract.2015 Jan;107(1):104-12. doi: 10.1016/j.diabres.2014.09.047. Epub 2014 Oct 7.
- PMID 25458330
- Unresolved controversies in gestational diabetes: implications on maternal and infant health.
- Barbour LA1.
- Current opinion in endocrinology, diabetes, and obesity.Curr Opin Endocrinol Diabetes Obes.2014 Aug;21(4):264-70. doi: 10.1097/MED.0000000000000080.
- PMID 24937040
- Octreotide: a novel therapy for refractory sulfonylurea-induced hypoglycemia.
- Barkin JA, Block HM, Mendez PE.
- Pancreas.Pancreas.2013 May;42(4):722-3. doi: 10.1097/MPA.0b013e3182769c26.
- PMID 23591434
Japanese Journal
- Improved glycaemic control with metformin-glibenclamide combined tablet therapy (Glucovance) in Type 2 diabetic patients inadequately controlled on metformin
Related Links
- Glucovance (glyburide and metformin) is used to treat type 2 diabetes (non-insulin dependent). Includes Glucovance side effects, interactions and indications. ... Glucovance side effects Get emergency medical help if you have any of ...
- GLUCOVANCE (glyburide and metformin) is available for oral administration in tablets containing 1.25 mg glyburide with 250 mg metformin hydrochloride, 2.5 mg glyburide with 500 mg metformin hydrochloride, and 5 mg glyburide ...
Related Pictures